Citius Oncology, Inc. (CTOR)
1.105
-0.06
(-4.74%)
USD |
NASDAQ |
Dec 10, 11:24
Citius Oncology EPS Diluted (Quarterly): -0.075 for June 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Citius Pharmaceuticals, Inc. | -0.7986 |
| Amicus Therapeutics, Inc. | 0.0558 |
| Soligenix, Inc. | -0.5846 |
| Tonix Pharmaceuticals Holding Corp. | -3.587 |
| GT Biopharma, Inc. | -0.8268 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.37M |
| Total Expenses (Quarterly) | 5.37M |
| Enterprise Value | 94.71M |
| Earnings Yield | -25.00% |